PT Pyridam Farma Tbk (PYFA.JK)
IDR 208.0
(-3.7%)
IDR 208.0
(-3.7%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1521.23 Billion IDR | 0.04% |
| 2022 | 1520.56 Billion IDR | 88.6% |
| 2021 | 806.22 Billion IDR | 252.72% |
| 2020 | 228.57 Billion IDR | 19.81% |
| 2019 | 190.78 Billion IDR | 1.99% |
| 2018 | 187.05 Billion IDR | 17.23% |
| 2017 | 159.56 Billion IDR | -4.49% |
| 2016 | 167.06 Billion IDR | 4.45% |
| 2015 | 159.95 Billion IDR | -7.31% |
| 2014 | 172.55 Billion IDR | -1.46% |
| 2013 | 175.11 Billion IDR | 28.91% |
| 2012 | 135.84 Billion IDR | 15.09% |
| 2011 | 118.03 Billion IDR | 17.34% |
| 2010 | 100.58 Billion IDR | 0.65% |
| 2009 | 99.93 Billion IDR | 1.3% |
| 2008 | 98.65 Billion IDR | 3.68% |
| 2007 | 95.15 Billion IDR | 14.47% |
| 2006 | 83.12 Billion IDR | 8.59% |
| 2005 | 76.55 Billion IDR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 1912.19 Billion IDR | 25.7% |
| 2024 Q3 | 5892.99 Billion IDR | -4.37% |
| 2024 Q2 | 6162.58 Billion IDR | 222.28% |
| 2023 Q4 | 1521.23 Billion IDR | -2.38% |
| 2023 Q1 | 1488.16 Billion IDR | -2.13% |
| 2023 Q2 | 1515.03 Billion IDR | 1.81% |
| 2023 FY | 1521.23 Billion IDR | 0.04% |
| 2023 Q3 | 1558.24 Billion IDR | 2.85% |
| 2022 Q2 | 1224.17 Billion IDR | -1.57% |
| 2022 FY | 1520.56 Billion IDR | 88.6% |
| 2022 Q4 | 1520.56 Billion IDR | 0.24% |
| 2022 Q1 | 1243.72 Billion IDR | 54.27% |
| 2022 Q3 | 1516.96 Billion IDR | 23.92% |
| 2021 Q3 | 627.53 Billion IDR | 8.58% |
| 2021 Q2 | 577.96 Billion IDR | 1.55% |
| 2021 Q1 | 569.15 Billion IDR | 149.0% |
| 2021 FY | 806.22 Billion IDR | 252.72% |
| 2021 Q4 | 806.22 Billion IDR | 28.47% |
| 2020 Q1 | 205.05 Billion IDR | 7.48% |
| 2020 FY | 228.57 Billion IDR | 19.81% |
| 2020 Q4 | 228.57 Billion IDR | 4.56% |
| 2020 Q3 | 218.61 Billion IDR | 8.64% |
| 2020 Q2 | 201.22 Billion IDR | -1.86% |
| 2019 Q3 | 189.74 Billion IDR | 2.87% |
| 2019 Q4 | 190.78 Billion IDR | 0.55% |
| 2019 Q2 | 184.44 Billion IDR | -3.59% |
| 2019 FY | 190.78 Billion IDR | 1.99% |
| 2019 Q1 | 191.3 Billion IDR | 2.27% |
| 2018 Q1 | 183.2 Billion IDR | 14.81% |
| 2018 FY | 187.05 Billion IDR | 17.23% |
| 2018 Q4 | 187.05 Billion IDR | -0.21% |
| 2018 Q3 | 187.45 Billion IDR | 1.44% |
| 2018 Q2 | 184.79 Billion IDR | 0.87% |
| 2017 FY | 159.56 Billion IDR | -4.49% |
| 2017 Q2 | 165.64 Billion IDR | -1.81% |
| 2017 Q1 | 168.7 Billion IDR | 0.98% |
| 2017 Q3 | 164.01 Billion IDR | -0.99% |
| 2017 Q4 | 159.56 Billion IDR | -2.71% |
| 2016 Q3 | 160.12 Billion IDR | -4.09% |
| 2016 Q1 | 162.64 Billion IDR | 1.69% |
| 2016 FY | 167.06 Billion IDR | 4.45% |
| 2016 Q4 | 167.06 Billion IDR | 4.33% |
| 2016 Q2 | 166.96 Billion IDR | 2.65% |
| 2015 Q3 | 170.34 Billion IDR | -2.5% |
| 2015 FY | 159.95 Billion IDR | -7.31% |
| 2015 Q1 | 174.12 Billion IDR | 0.91% |
| 2015 Q2 | 174.71 Billion IDR | 0.34% |
| 2015 Q4 | 159.95 Billion IDR | -6.1% |
| 2014 Q4 | 172.55 Billion IDR | 1.42% |
| 2014 FY | 172.55 Billion IDR | -1.46% |
| 2014 Q3 | 170.14 Billion IDR | -1.73% |
| 2014 Q2 | 173.14 Billion IDR | -4.77% |
| 2014 Q1 | 181.82 Billion IDR | 3.83% |
| 2013 FY | 175.11 Billion IDR | 28.91% |
| 2013 Q2 | 158.72 Billion IDR | 11.96% |
| 2013 Q3 | 167.72 Billion IDR | 5.67% |
| 2013 Q4 | 175.11 Billion IDR | 4.41% |
| 2013 Q1 | 141.76 Billion IDR | 4.36% |
| 2012 Q1 | 119.54 Billion IDR | 1.28% |
| 2012 FY | 135.84 Billion IDR | 15.09% |
| 2012 Q2 | 121.84 Billion IDR | 1.92% |
| 2012 Q3 | 131.06 Billion IDR | 7.57% |
| 2012 Q4 | 135.84 Billion IDR | 3.65% |
| 2011 Q4 | 118.03 Billion IDR | 0.0% |
| 2011 FY | 118.03 Billion IDR | 17.34% |
| 2010 FY | 100.58 Billion IDR | 0.65% |
| 2009 FY | 99.93 Billion IDR | 1.3% |
| 2008 FY | 98.65 Billion IDR | 3.68% |
| 2007 FY | 95.15 Billion IDR | 14.47% |
| 2006 FY | 83.12 Billion IDR | 8.59% |
| 2005 FY | 76.55 Billion IDR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| PT Darya-Varia Laboratoria Tbk | 2043.48 Billion IDR | 25.557% |
| PT Merck Tbk | 957.81 Billion IDR | -58.823% |
| PT Phapros, Tbk | 1765.88 Billion IDR | 13.855% |
| PT Industri Jamu dan Farmasi Sido Muncul Tbk | 3890.7 Billion IDR | 60.901% |
| PT Tempo Scan Pacific Tbk | 11315.73 Billion IDR | 86.556% |